IO Frontiers World 2019

Download the Regenerative Medicine CMOs in Japan Infographic

There are currently ten noteworthy regenerative medicine CMOs in operation in Japan. Most service providers focus on the PMD. Act route to market, but a few also provide services for those looking to enter the market under the ASRM route.

reg med in japan

To find out more, fill out the form below.

Form 'FB_11822D12-5056-B731-4CE428726AACC48E' not found.



  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy